CILATOP TRIO 25
| Brand | CILATOP TRIO 25 |
|---|---|
| Composition | Telmisartan 40mg + Cilnidipine 10mg + Metoprolol Succinate 25 mg (as extended release) |
| Packing | 10x10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about CILATOP TRIO 25Indication
Management of essential hypertension (high blood pressure) in patients requiring combination therapy.
Mechanism of action
Telmisartan blocks angiotensin II type-1 (AT1) receptors, reducing blood vessel narrowing. Cilnidipine blocks L-type and N-type calcium channels, relaxing vascular smooth muscle and reducing sympathetic neurotransmitter release. Metoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate and cardiac output.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
CILATOP TRIO 25 for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
BISINTRA-TM 2.5/40 TABS
CILATOP-5
TELMIWAL-40
TELMIWAL-M